Methoxyurea
Methoxyurea (Compound 3) is a potential regulator of nitric oxide (NO) donors that acts on hemoglobins such as oxy-hemoglobin (OxyHb) and met-hemoglobin (MetHb) . Methoxyurea is promising for research of sickle cell disease (SCD) [1].
Product Specifications
CAS Number
3272-27-3
UNSPSC
12352211
Hazard Statement
H302-H315-H319-H335
Target
Hemoglobin
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cardiovascular Disease
Smiles
O=C(N)NOC
Molecular Formula
C2H6N2O2
Molecular Weight
90.08
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
References & Citations
[1]Vankayala SL, et al. Unlocking the binding and reaction mechanism of hydroxyurea substrates as biological nitric oxide donors. J Chem Inf Model. 2012 May 25;52 (5) :1288-97.
Shipping Conditions
Room temperature
Scientific Category
Reference compound2
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
G8957-01M-AP 200 µL
Granzyme B, CT (GRB, GZMB, C11, Cathespin G-like 1, CCPI, CGL1, CGL-1, CSPB, CSP-B, CTLA1, CTLA-1, CTSGL1, Cytotoxic T Lymphocyte-associated Serine Esterase 1, Cytotoxic T Lymphocyte Proteinase 2, Fragmentin 2, Fragmentin-2, Granzyme 2, Human Lymphocyte Protein, HLP, Lymphocyte Protease, Protease Serine B, SECT, T-cell Serine Protease 1-3E) (AP) discontinued
Sign In for Pricing
View Details 
246381-ML650 100 µL
FTL (Ferritin, Light Polypeptide, MGC71996) (MaxLight 650)
Sign In for Pricing
View Details